Yuka Sugimoto

スギモトユカ | Yuka Sugimoto

Affiliation and department：
Job title： Associate professor

Research field (1)： Hematology and oncology

Research keywords (3)： hematopoietic stem cells , Hematology , Myeloproliferative neoplasms

Papers (61)：

Emiko Kashima, Yuka Sugimoto, Keiki Nagaharu, Eiko Ohya, Makoto Ikejiri, Yasuyuki Watanabe, Shinichi Kageyama, Koji Oka, Isao Tawara. Venetoclax is effective for chronic myelomonocytic leukemia blastic transformation with RUNX1 mutation. Hematology (Amsterdam, Netherlands). 2024. 29. 1. 2392908-2392908
Yuka Sugimoto, Keiki Nagaharu, Eiko Ohya, Kohshi Ohishi, Isao Tawara, Tomoki Ito, Akihiko Gotoh, Mika Nakamae, Fumihiko Kimura, Michiaki Koike, et al. Clinical characteristics in adolescents and young adults with polycythemia vera and essential thrombocythemia in Japan. International Journal of Hematology. 2024
Keita Kirito, Yuka Sugimoto, Akihiko Gotoh, Katsuto Takenaka, Michiko Ichii, Tadaaki Inano, Shuichi Shirane, Masafumi Ito, Oleh Zagrijtschuk, Albert Qin, et al. Long-term safety and efficacy of ropeginterferon alfa-2b in Japanese patients with polycythemia vera. International journal of hematology. 2024
Keiki Nagaharu, Eiko Ohya, Yoko Edahiro, Yoshinori Hashimoto, Tomoki Ito, Akihiko Gotoh, Mika Nakamae, Fumihiko Kimura, Michiaki Koike, Keita Kirito, et al. Correction to: Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysis. Annals of hematology. 2024. 103. 10. 4349-4350
Keiki Nagaharu, Eiko Ohya, Yoko Edahiro, Yoshinori Hashimoto, Tomoki Ito, Akihiko Gotoh, Mika Nakamae, Fumihiko Kimura, Michiaki Koike, Keita Kirito, et al. Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysis. Annals of hematology. 2024

ｍore...

MISC (136)：

杉本由香. 骨髄線維症に対する治療薬の臨床効果と開発動向. 血液内科. 2024. 89. 2. 228-234
新家直樹, 松本剛史, 中村彰秀, 塩谷拓也, 伊野和子, 杉本由香, 俵功. エミシズマブ定期投与中に胆嚢出血を来し腹腔鏡下胆嚢摘出術を施行したインヒビター保有血友病A患者の1例. 臨床血液. 2024. 65. 8. 841-841
中村彰秀, 杉本由香. 各科ローテ準備ガイド:前編~診療科別・有意義な研修期間を過ごすためのアドバイス血液内科データを読み解くコツと抗がん薬治療時の全身管理を学ぼう!. レジデントノート. 2024. 26. 1. 113-115
杉本由香. 【各種造血器腫瘍に対する治療のState of the Art】骨髄線維症の最新治療. 腫瘍内科. 2024. 33. 4. 333-340
杉本由香, 小松則夫. 真性多血症におけるロペグインターフェロンアルファ-2bの臨床的有用性 : 科学的エビデンスと臨床経験に基づいた知見-Clinical benefit of ropeginterferon alfa-2b for the patients with polycythemia vera : Based on scientific evidence and clinical experience. 血液内科 = Hematology / 血液内科編集委員会編. 2023. 87. 5. 588-598

ｍore...

Books (6)：

EBM血液疾患の治療2023-2024
中外医学社 2022 ISBN:9784498225404
EBM血液疾患の治療2021-2022
中外医学社 2021 ISBN:9784498225244
がん診療スタンダードマニュアル : がん薬物療法からサポーティブケアまで
シーニュ 2019 ISBN:9784990950569
内科学書
中山書店 2019 ISBN:9784521747491
即引き!薬の必須検査値チェックブック
南江堂 2017 ISBN:9784524259618

ｍore...

Education (2)：

2001 - 2005 Mie University
1990 - 1996 Mie University School of Medicine

Work history (10)：

2022/01 - 現在 Mie University Graduate School of Medicine, Department of Hematology and Oncology associate professor
2019/07 - 2021/12 Mie University Department of Community Hematology Associate Professor
2018/06 - 2019/06 Mie University Hospital Department of Hematology Assistant Professor
2016/04 - 2018/05 Mie University Hospital Clinical training and Career support Center Assistant Professor
2012/05 - 2016/03 Mie University School of Medicine Department of Hematology Assistant Professor

Show all

Awards (2)：

2011 - 公益財団法人三重県健康管理事業センターがん研究助成
2007 - 三重県医師会医学研究奨励賞

Association Membership(s) (10)：

The Japan Society of Human Genetics , THE JAPAN SOCIETY FOR MEDICAL EDUCATION , 日本造血細胞移植学会 , THE JAPAN SOCIETY OF TRANSFUSION MEDICINE AND CELL THERAPY , 日本骨髄腫学会 , アメリカ血液学会 , THE JAPANESE CANCER ASSOCIATION , 日本臨床腫瘍学会 , THE JAPANESE SOCIETY OF INTERNAL MEDICINE , THE JAPANESE SOCIETY OF HEMATOLOGY

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page